Last reviewed · How we verify
NCT05988567
Efficacy Testing of Melon Oil Olive Pressed Candy Products
NA trial testing Placebo candy in Skin Condition in 60 participants. Completed in 31 December 2023.
1 June 2023
Quick facts
| Lead sponsor | TCI Co., Ltd. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | other |
| Enrollment | 60 |
| Start date | 9 May 2023 |
| Primary completion | 1 June 2023 |
| Estimated completion | 31 December 2023 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- Placebo candy
- melon and oil olive pressed candy
Conditions studied
- Skin Condition — all drugs for Skin Condition →
Sponsor
TCI Co., Ltd. — full company profile →
Who can join
18 and older, any sex, with Skin Condition. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To assess melon and oil olive pressed candy on skin condition improvement
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Multi-Plant Concentrated Powder Improved Skin Whitening: A Double-Blinded, Randomized, and Placebo-Controlled Clinical Study.
He Y, Bu Y, Chiang CF, Lin YH, et al · · 2025 · PMID 39927597 · DOI 10.1111/jocd.70011
Verify or expand the search:
- PubMed search for NCT05988567
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Skin Condition
Currently open trials in the same condition.
- NCT07379216 — Efficacy Evaluation Study of Vitamin C and Glutathione Liquid Sachet · NA · recruiting
- NCT06775132 — Associations Between Dietary Intake and Cardiometabolic and Gut Microbiota Outcomes · recruiting
- NCT06727292 — Biometrical Evaluation of the Efficacy of a Food Supplement Versus Placebo · NA · recruiting
- NCT06724627 — Application of the Belle.AI Dermatological Image Reference System for Patient Diagnosis in an Active Clinical Setting · NA · recruiting
- NCT06157567 — Clinical Feasibility Study to Evaluate the Safety and Performance of the Profound Matrix System · NA · active not recruiting
Other TCI Co., Ltd. trials
Trials by the same sponsor.
- NCT07379216 — Efficacy Evaluation Study of Vitamin C and Glutathione Liquid Sachet · NA · recruiting
- NCT07302828 — Effect of Double Nutri® Liposomal Encapsulation Technology on Human Absorption of Vitamin C and Glutathione Liquid Sache · NA · completed
- NCT07172607 — The Effect of Avnace eZZe on Sleep Improvement · NA · recruiting
- NCT07097987 — Evaluation of the Efficacy of the Composite WM Formula in Promoting GLP-1 Secretion · NA · not yet recruiting
- NCT07097974 — Evaluation of the Efficacy of the Composite WM Formula in Body Weight Change · NA · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05988567 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by TCI Co., Ltd.
- Last refreshed: 21 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05988567.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing